Wnt signaling in prostate development and carcinogenesis
- PMID: 21475372
- DOI: 10.5507/bp.2011.016
Wnt signaling in prostate development and carcinogenesis
Abstract
Background: The Wnt signaling pathway is crucial for cell fate decisions, stem cell renewal, regulation of cell proliferation and differentiation. Deregulated Wnt signaling is also implicated in a number of hereditary and degenerative diseases and cancer.
Methods and results: This review highlights the role of the Wnt pathway in the regulation of stem/progenitor cell renewal and prostate gland development and how this signaling is altered in prostate cancer. Recent evidence suggests that Wnt signaling regulates androgen activity in prostate cancer cells, enhances androgen receptor expression and promotes the growth of prostate cancer even after androgen ablation therapy. There is also strong evidence that Wnt signaling is enhanced in androgen-ablation resistant tumors and bone metastases.
Conclusions: Further study of the modulators of this pathway will be of therapeutic relevance as inhibition of Wnt signaling may have the potential to reduce the self-renewal and aggressive behaviour of prostate cancer while Wnt signaling activation might enhance stem cell activity when tissue regeneration is required.
Similar articles
-
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.Cell Res. 2009 Jun;19(6):683-97. doi: 10.1038/cr.2009.43. Cell Res. 2009. PMID: 19365403
-
Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.J Cell Biochem. 2006 Oct 1;99(2):402-10. doi: 10.1002/jcb.20983. J Cell Biochem. 2006. PMID: 16741972 Review.
-
The role of Wnt signaling in cancer and stem cells.Future Oncol. 2005 Dec;1(6):787-97. doi: 10.2217/14796694.1.6.787. Future Oncol. 2005. PMID: 16556058 Review.
-
WNT signaling pathway and stem cell signaling network.Clin Cancer Res. 2007 Jul 15;13(14):4042-5. doi: 10.1158/1078-0432.CCR-06-2316. Clin Cancer Res. 2007. PMID: 17634527 Review.
-
Wnt signaling and prostate cancer.Curr Drug Targets. 2008 Jul;9(7):571-80. doi: 10.2174/138945008784911831. Curr Drug Targets. 2008. PMID: 18673243 Review.
Cited by
-
Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC.Sci Rep. 2020 Dec 14;10(1):21924. doi: 10.1038/s41598-020-78774-5. Sci Rep. 2020. PMID: 33318499 Free PMC article.
-
Why are epididymal tumours so rare?Asian J Androl. 2012 May;14(3):465-75. doi: 10.1038/aja.2012.20. Epub 2012 Apr 23. Asian J Androl. 2012. PMID: 22522502 Free PMC article. Review.
-
SOX4: The unappreciated oncogene.Semin Cancer Biol. 2020 Dec;67(Pt 1):57-64. doi: 10.1016/j.semcancer.2019.08.027. Epub 2019 Aug 21. Semin Cancer Biol. 2020. PMID: 31445218 Free PMC article. Review.
-
Oncogenic and tumor-suppressive microRNAs in prostate cancer.Curr Opin Endocr Metab Res. 2020 Feb;10:50-59. doi: 10.1016/j.coemr.2020.02.002. Epub 2020 Feb 27. Curr Opin Endocr Metab Res. 2020. PMID: 33043165 Free PMC article.
-
Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges.J Carcinog. 2012;11:4. doi: 10.4103/1477-3163.93001. Epub 2012 Feb 17. J Carcinog. 2012. PMID: 22438770 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical